These symptoms may indicate acute coronary syndrome (including myocardial infarction), pulmonary embolism, aortic dissection, or other life-threatening conditions
Tambini also outlined the potential risks of these supplements including inconsistent dosages, hidden or harmful ingredients, and the possibility of interfering with other medications
These results align with findings from previous NMAs, ITCs and the head-to-head SURMOUNT-5 trial, where the NMA results support the relative strength of tirzepatide compared to liraglutide and semaglutide in achieving weight reduction and reducing cardiometabolic risk factors among patients with obesity or overweight
In this context, a fibre supplement like ispaghula may actually provide symptomatic relief and help maintain regular bowel movements
It is used as an anti-obesity alternative medicine and induces fat breakdown as well as preventing inflammation